Table 2.
Site of Thoracic Involvement | Infectious Granulomatous Diseases | Non-Infectious Granulomatous Diseases |
---|---|---|
Lung parenchyma | Tuberculosis | Hypersensitivity pneumonitis (many causal antigens) |
NTM infections | Chemical induced granulomatosis (e.g., beryllium, aluminum, zirconium, silica, and talc) | |
Histoplasmosis (very rare in Europe) | Drug-induced granulomatosis (e.g., TNF-alpha antagonists, immune checkpoint inhibitors, targeted therapies, and interferons) | |
Parasitic infections (very rare, e.g., leishmaniosis, paragonimiasis, and schistosomiasis), occurring mainly in endemic countries | Aspiration pneumonia with foreign body granulomatosis | |
Viral infections (very rare, e.g., varicella zoster and cytomegalovirus), mainly in immunocompromised patients) | Vasculitis, CTD, and inflammatory disease (e.g., GPA, EGPA, NSG, ILD in Sjogren’s syndrome, and Crohn’s disease) | |
Other infections (very rare, e.g., Whipple’s disease, cryptococcosis, coccidioidomycosis, and mucormycosis), mainly in immunocompromised patients | Immune deficiency granulomatosis (e.g., granulomatous-associated CVID and CGD) | |
Genetic disorders: Blau syndrome | ||
Malignancy-associated granulomatosis (e.g., cancer and lymphoma) | ||
Other proliferative disorders (e.g., LCH, ECD, and lymphomatoid granulomatosis) | ||
Thoracic lymph nodes | Tuberculosis | Sarcoid-like reaction (especially occurring in linkage to malignancies but also in rare occasions of hypersensitivity pneumonitis and CTD such as Sjogren’s syndrome) |
NTM infections | Chemical-induced granulomatosis (e.g., beryllium, aluminum, zirconium, silica, and talc) | |
Histoplasmosis (very rare in Europe) | Drug-induced granulomatosis (e.g., TNF-alpha antagonists, immune checkpoint inhibitors, targeted therapies, and interferons) | |
Other infections (very rare, e.g., Whipple’s disease and fungal infections) | Immune deficiency granulomatosis (e.g., granulomatous-associated CVID and CGD) | |
Malignancy-associated granulomatosis (e.g., cancer and lymphoma) |
Definition of abbreviations: CGD, chronic granulomatous disease; CTD, connective tissue disease; CVID, common variable immune deficiency; ECD, Erdheim–Chester disease; EGPA, eosinophilic granulomatosis with polyangiitis; GPA, granulomatosis with polyangiitis; ILD, interstitial lung disease; LCH, Langerhans cell histiocytosis; NSG, necrotizing sarcoid granulomatosis; NTM, nontuberculous mycobacteria; TNF, tumor necrosis factor. The differential diagnosis should be prioritized on the basis of the individual’s clinical history and presentation and can depend on geographic location.